Cell Surface Marker Detection Market Size, Share, and Trends 2024 to 2034

The global cell surface marker detection market size is calculated at USD 6.16 billion in 2025 and is forecasted to reach around USD 12.81 billion by 2034, accelerating at a CAGR of 8.47% from 2025 to 2034. The North America market size surpassed USD 2.27 billion in 2024 and is expanding at a CAGR of 8.62% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year

  • Last Updated : February 2025
  • Report Code : 5575
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis 
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on Cell Surface Marker Detection Market

5.1. COVID-19 Landscape: Cell Surface Marker Detection Industry Impact
5.2. COVID-19  Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers

Chapter 8. Global Cell Surface Marker Detection Market, By Product

8.1. Cell Surface Marker Detection Market, by Product
8.1.1. Flow Cytometry 
8.1.1.1. Market Revenue and Forecast 
8.1.2. Hematology Analyzers 
8.1.2.1. Market Revenue and Forecast 
8.1.3. Reagents & Kits
8.1.3.1. Market Revenue and Forecast

Chapter 9. Global Cell Surface Marker Detection Market, By Application

9.1. Cell Surface Marker Detection Market, by Application
9.1.1. Disease Diagnosis & Identification 
9.1.1.1. Market Revenue and Forecast 
9.1.2. Research & Drug Discovery 
9.1.2.1. Market Revenue and Forecast 
9.1.3. Others 
9.1.3.1. Market Revenue and Forecast

Chapter 10. Global Cell Surface Marker Detection Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Product 
10.1.2. Market Revenue and Forecast, by Application 
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product 
10.1.3.2. Market Revenue and Forecast, by Application 
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product 
10.1.4.2. Market Revenue and Forecast, by Application 
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product 
10.2.2. Market Revenue and Forecast, by Application 
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product 
10.2.3.2. Market Revenue and Forecast, by Application 
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product 
10.2.4.2. Market Revenue and Forecast, by Application 
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product 
10.2.5.2. Market Revenue and Forecast, by Application 
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product 
10.2.6.2. Market Revenue and Forecast, by Application 
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product 
10.3.2. Market Revenue and Forecast, by Application 
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product 
10.3.3.2. Market Revenue and Forecast, by Application 
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product 
10.3.4.2. Market Revenue and Forecast, by Application 
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product 
10.3.5.2. Market Revenue and Forecast, by Application 
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product 
10.3.6.2. Market Revenue and Forecast, by Application 
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product 
10.4.2. Market Revenue and Forecast, by Application 
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product 
10.4.3.2. Market Revenue and Forecast, by Application 
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product 
10.4.4.2. Market Revenue and Forecast, by Application 
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product 
10.4.5.2. Market Revenue and Forecast, by Application 
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product 
10.4.6.2. Market Revenue and Forecast, by Application 
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product 
10.5.2. Market Revenue and Forecast, by Application 
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product 
10.5.3.2. Market Revenue and Forecast, by Application 
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product 
10.5.4.2. Market Revenue and Forecast, by Application

Chapter 11. Company Profiles

11.1. Abbott Laboratories 
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Danaher Corporation (Beckman Coulter Inc.) 
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Becton, Dickinson, and Company 
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bio Rad Laboratories Inc. 
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. F. Hoffmann-La Roche Ltd 
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Diasorin SpA (Luminex Corporation) 
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Nihon Kohden Corporation 
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Qiagen NV 
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Siemens Healthineers 
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Thermo Fisher Scientific Inc. 
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global cell surface marker detection market size is expected to grow from USD 5.68 billion in 2024 to USD 12.81 billion by 2034.

The cell surface marker detection market is anticipated to grow at a CAGR of 8.47% between 2025 and 2034.

The major players operating in the cell surface marker detection market are Abbott Laboratories, Danaher Corporation (Beckman Coulter Inc.), Becton, Dickinson, and Company, Bio Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Diasorin SpA (Luminex Corporation), Nihon Kohden Corporation, Qiagen NV, Siemens Healthineers, Thermo Fisher Scientific Inc.

The driving factors of the cell surface marker detection market are the rising advancements in diagnostic technologies are enhancing the efficiency and accuracy of cell surface marker detection, which is expected to drive market growth.

North America region will lead the global cell surface marker detection market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client